Sana Biotechnology, Inc.
US ˙ NasdaqGS ˙ US7995661045

SecuritySANA / Sana Biotechnology, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership224,246 shares
Latest Disclosed Value $ 612,191
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in SANA / Sana Biotechnology, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 224,246 shares of Sana Biotechnology, Inc. (US:SANA) valued at $612,192 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 224,246 shares of Sana Biotechnology, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $600,979 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Sana Biotechnology EC US7995661045 224,246 0 0.00 612 62.77 0.0137
2025-05-28 2025-03-31 NP Sana Biotechnology EC US7995661045 224,246 0 0.00 377 3.01 0.0090
2025-02-25 2024-12-31 NP Sana Biotechnology EC US7995661045 224,246 -39,352 -14.93 366 -66.70 0.0080
2024-11-26 2024-09-30 NP Sana Biotechnology EC US7995661045 263,598 84,744 47.38 1,097 12.30 0.0207
2024-08-26 2024-06-30 NP Sana Biotechnology EC US7995661045 178,854 13,050 7.87 977 -41.13 0.0199
2024-05-28 2024-03-31 NP Sana Biotechnology EC US7995661045 165,804 0 0.00 1,658 145.27 0.0346
2024-02-26 2023-12-31 NP Sana Biotechnology EC US7995661045 165,804 12,243 7.97 676 13.80 0.0144
2023-11-28 2023-09-30 NP Sana Biotechnology EC US7995661045 153,561 -7,532 -4.68 594 -38.12 0.0155
2023-08-25 2023-06-30 NP Sana Biotechnology EC US7995661045 161,093 20,143 14.29 960 108.70 0.0228
2023-05-26 2023-03-31 NP Sana Biotechnology EC US7995661045 140,950 0 0.00 461 -17.27 0.0123
2023-02-24 2022-12-31 NP Sana Biotechnology EC US7995661045 140,950 0 0.00 557 -34.20 0.0153
2022-11-25 2022-09-30 NP Sana Biotechnology EC US7995661045 140,950 4,853 3.57 846 -3.43 0.0242
2022-08-25 2022-06-30 NP Sana Biotechnology EC US7995661045 136,097 0 0.00 875 -22.15 0.0242
2022-05-26 2022-03-31 NP Sana Biotechnology EC US7995661045 136,097 5,004 3.82 1,124 -44.60 0.0262
2022-02-25 2021-12-31 NP Sana Biotechnology EC US7995661045 131,093 0 0.00 2,029 -31.27 0.0440
2021-11-24 2021-09-30 NP Sana Biotechnology EC US7995661045 131,093 91,759 233.28 2,952 281.89 0.0650
2021-08-26 2021-06-30 NP Sana Biotechnology EC US7995661045 39,334 39,334 773 0.0166
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.